Pricing Log in Create free account
Friday 6 November 2026 Export RGEN’s income statement to Excel — free account

Repligen Corporation

RGEN Healthcare Medical Instruments & Supplies

Repligen Corporation’s revenue for fiscal 2025 (year ended December 2025) was $738.3 million, up 16.4% from fiscal 2024.

Revenue
+10.9%
EPS
−351.9%
Free cash flow
−11.5%
Total debt
+3.28%

Quarter to September 2026, against a year earlier

169.01 9.19 −5.16%
Market cap
$10.8B
P/E
0.0×
Fwd P/E
−615×
Dividend yield
—
F-score
6/9
Altman Z
7.49
Beneish M
−2.52
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Repligen Corporation (RGEN) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, Repligen Corporation (RGEN) trades at a EV/Sales of 11.6×. Over the past ten years it has ranged from 7.2× (June 2016) to 34.2× (September 2021); the current reading is higher than 31% of that period. That is above the Medical Instruments & Supplies industry median of 2.8× and above the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 12.3× (1.33%)
FY2024 12.4× (19.91%)
FY2023 15.5× 41.80%
FY2022 10.9× (48.74%)
FY2021 21.4× (18.70%)
FY2020 26.3× 70.23%
FY2019 15.4× 29.18%
FY2018 11.9× 17.13%
FY2017 10.2× 6.71%
FY2016 9.6× (6.98%)

Quarterly newest first

Period EV/Sales Change
Sep 2026 13.2× 38.04%
Jun 2026 9.6× 12.80%
Mar 2026 8.5× (30.91%)
Dec 2025 12.3× 17.70%
43 more quarters

Against its own ten years

Low 7.2× High 34.2×
Ten-year median 12.6×
Current reading's percentile 32

EV/Sales against peers

Company EV/Sales
BAX Baxter International Inc. compare 1.7×
AVTR Avantor, Inc. compare 2.0×
BLCO Bausch + Lomb Corporation compare 2.2×
SOLV Solventum Corporation compare 2.4×
ALGN Align Technology, Inc. compare 2.4×
ATR AptarGroup, Inc. compare 2.6×
COO The Cooper Companies, Inc. compare 3.5×
TFX Teleflex Incorporated compare 4.1×
RGEN Repligen Corporation 11.6×
Medical Instruments & Supplies industry median 2.8×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on RGEN